Evidence map›Paper›PMID 28962405›Full record

ArticleToxicology reports2015

Zn(II) released from zinc oxide nano/micro particles suppresses vasculogenesis in human endothelial colony-forming cells.

Saeko Tada-Oikawa, Gaku Ichihara, Yuka Suzuki, Kiyora Izuoka, Wenting Wu, Yoshiji Yamada, Takashi Mishima, Sahoko Ichihara

Open access · goldAbstract read
In one paragraph

Article in Toxicology reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Zinc and Skin Disorders.Nutrients · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Saeko Tada-OikawaGraduate School of Regional Innovation Studies, Mie University, Tsu, Japan.
Gaku IchiharaDepartment of Occupational and Environmental Health, Tokyo Univeristy of Science, Noda, Japan.
Yuka SuzukiGraduate School of Regional Innovation Studies, Mie University, Tsu, Japan.
Kiyora IzuokaGraduate School of Regional Innovation Studies, Mie University, Tsu, Japan.
Wenting WuDepartment of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yoshiji YamadaLife Science Research Center, Mie University, Tsu, Japan.
Takashi MishimaGraduate School of Regional Innovation Studies, Mie University, Tsu, Japan.
Sahoko IchiharaGraduate School of Regional Innovation Studies, Mie University, Tsu, Japan.
Mie University · JPNagoya University · JPTokyo University of Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zinc oxide (ZnO) nanoparticles have been widely used in industry, cosmetics, and biomedicine. Recent studies suggested that these nanoparticles could have a major impact on the cardiovascular system. Endothelial progenitor cells (EPCs) contribute to postnatal endothelial repair and regeneration. The present study dissected the effects of ZnO nanoparticles on vasculogenesis using human endothelial colony forming cells (ECFCs), which participate in post-natal vasculogenesis. Two types of ZnO particles were used (nano and micro), in addition to zinc chloride solutions with zinc ion concentrations equal to those in ZnO nanoparticles. Twenty-four-hour exposure induced cytotoxicity in a dose-dependent manner and increased ECFCs apoptosis in all groups. The exposure also reduced the functional capacity of ECFCs on Matrix gel to form tubules, compared with the control cells. These effects were associated with downregulation of expression of vascular endothelial growth factor receptor, VEGFR2 and CXC chemokine receptor, CXCR4. The results suggest that ZnO nanoparticles suppress vasculogenesis from ECFCs through downregulation of the expression of receptors related to vasculogenesis. These effects are based the concentration of released Zn(II).

Indexed as

CXCR4CXCR4, CX chemokine receptorECFCs, endothelial colony forming cellsEndothelial progenitor cellsEPCs, endothelial progenitor cellsICP-AES, inductively coupled plasma atomic emission spectrometryNanoparticlesPdI, polydispersity indexTube formationVasculogenesisVEGFR2VEGFR2, vascular endothelial growth factor A receptor 2Zinc oxideZnCl2, zinc chlorideZnO, zinc oxide

Identifiers

PMID28962405
PMCPMC5598154
OpenAlexW1974346525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.